Clinical Outcomes for STEMI Patients with Stress Hyperglycemia, 2020-2024

A retrospective analysis of 818 first-time ST-segment elevation myocardial infarction (STEMI) patients who underwent emergency percutaneous coronary intervention (PCI) between July 2020 and February 2024. The dataset, authored by Kaidong Zeng and shared under a CC-BY-4.0 license, compares major adverse cardiovascular events (MACE) across patient groups defined by diabetes history and blood glucose levels.

Use Cases

• Assess the independent risk factor of stress hyperglycemia (SHG) for in-hospital all-cause mortality based on patient classification.
• Model long-term cardiovascular outcomes based on baseline cardiac function and coronary artery disease severity.
• Evaluate the prognostic value of fasting blood glucose and glycated hemoglobin levels in non-diabetic STEMI patients.

Strengths

• Dataset includes 818 patient records with clear classification into three groups (SHG, non-SHG, diabetes).
• Study reports specific statistical findings, including an odds ratio of 4.68 for SHG as a risk factor for in-hospital mortality.
• Data covers both short-term (in-hospital) and long-term (one-year) clinical outcomes.

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment.
• Data may reflect temporal bias inherent to the single-center retrospective study design.

Provenance

Source

figshare

Collection Method

Retrospective analysis of patient records.

Time Range

July 2020 to February 2024

Freshness

Last updated 2026-05-14 04:28:23; freshness should be verified.